Ambev (ABEV) Competitors $2.02 -0.10 (-4.72%) (As of 05:44 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ABEV vs. DEO, KDP, STZ, BF.B, COCO, NAPA, WEST, BRCC, CASK, and IBGShould you be buying Ambev stock or one of its competitors? The main competitors of Ambev include Diageo (DEO), Keurig Dr Pepper (KDP), Constellation Brands (STZ), Brown-Forman (BF.B), Vita Coco (COCO), Duckhorn Portfolio (NAPA), Westrock Coffee (WEST), BRC (BRCC), Heritage Distilling (CASK), and Innovation Beverage Group (IBG). These companies are all part of the "beverages" industry. Ambev vs. Diageo Keurig Dr Pepper Constellation Brands Brown-Forman Vita Coco Duckhorn Portfolio Westrock Coffee BRC Heritage Distilling Innovation Beverage Group Ambev (NYSE:ABEV) and Diageo (NYSE:DEO) are both large-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, community ranking, profitability, dividends and earnings. Do analysts rate ABEV or DEO? Ambev presently has a consensus price target of $2.70, suggesting a potential upside of 33.66%. Given Ambev's stronger consensus rating and higher possible upside, research analysts clearly believe Ambev is more favorable than Diageo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ambev 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Diageo 2 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is ABEV or DEO a better dividend stock? Ambev pays an annual dividend of $0.12 per share and has a dividend yield of 5.9%. Diageo pays an annual dividend of $5.01 per share and has a dividend yield of 4.0%. Ambev pays out 66.7% of its earnings in the form of a dividend. Diageo pays out 72.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Ambev is clearly the better dividend stock, given its higher yield and lower payout ratio. Which has preferable earnings & valuation, ABEV or DEO? Diageo has lower revenue, but higher earnings than Ambev. Ambev is trading at a lower price-to-earnings ratio than Diageo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmbev$82.41B0.39$2.90B$0.1811.22Diageo$20.27B3.44$3.87B$6.9018.17 Which has more risk and volatility, ABEV or DEO? Ambev has a beta of 1.05, indicating that its share price is 5% more volatile than the S&P 500. Comparatively, Diageo has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Is ABEV or DEO more profitable? Ambev has a net margin of 17.02% compared to Diageo's net margin of 0.00%. Ambev's return on equity of 16.12% beat Diageo's return on equity.Company Net Margins Return on Equity Return on Assets Ambev17.02% 16.12% 10.48% Diageo N/A N/A N/A Does the MarketBeat Community believe in ABEV or DEO? Ambev received 83 more outperform votes than Diageo when rated by MarketBeat users. Likewise, 60.80% of users gave Ambev an outperform vote while only 59.28% of users gave Diageo an outperform vote. CompanyUnderperformOutperformAmbevOutperform Votes38060.80% Underperform Votes24539.20% DiageoOutperform Votes29759.28% Underperform Votes20440.72% Does the media favor ABEV or DEO? In the previous week, Ambev had 2 more articles in the media than Diageo. MarketBeat recorded 11 mentions for Ambev and 9 mentions for Diageo. Diageo's average media sentiment score of 0.86 beat Ambev's score of 0.27 indicating that Diageo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ambev 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Diageo 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of ABEV or DEO? 8.1% of Ambev shares are owned by institutional investors. Comparatively, 9.0% of Diageo shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryAmbev beats Diageo on 12 of the 19 factors compared between the two stocks. Ad Porter & CompanyU.S. Government: “this could save civilization.”Experts indicate that ChatGPT alone consumes up to 17,000 times more electricity than the average U.S. household uses in a single day. And with companies like Google and Microsoft implementing AI into everything we do, that energy consumption is only going to exponentially increase. Thing is, outside of a small group of elite investors, nobody has connected the dots on how this military contractor could be the most important company in the AI boom.To get all the details, go here now. Get Ambev News Delivered to You Automatically Sign up to receive the latest news and ratings for ABEV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ABEV vs. The Competition Export to ExcelMetricAmbevBeverages IndustryStaples SectorNYSE ExchangeMarket Cap$31.82B$55.43B$14.07B$19.14BDividend Yield5.89%2.63%2.69%3.51%P/E Ratio11.2218.3221.9841.72Price / Sales0.3912.172.6716.78Price / Cash8.2522.8721.1421.73Price / Book1.984.735.845.27Net Income$2.90B$2.61B$572.90M$987.88M7 Day Performance-11.01%-3.23%-3.92%-5.42%1 Month Performance-6.91%4.58%-0.84%-2.60%1 Year Performance-31.41%-14.21%3.42%12.55% Ambev Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ABEVAmbev3.7709 of 5 stars$2.02-4.7%$2.70+33.7%-26.2%$31.82B$82.41B11.2242,774Dividend CutShort Interest ↓DEODiageo2.7663 of 5 stars$131.77+0.2%N/A-10.0%$73.30B$20.27B19.0330,367Positive NewsKDPKeurig Dr Pepper4.5872 of 5 stars$33.53-0.1%$38.50+14.8%+3.3%$45.48B$15.15B20.3321,700Positive NewsSTZConstellation Brands4.8705 of 5 stars$237.95-0.7%$288.70+21.3%-1.4%$43.20B$10.19B77.5610,600Positive NewsBF.BBrown-Forman2.0649 of 5 stars$44.38-1.3%$50.67+14.2%-25.4%$20.98B$4.08B21.225,700Analyst DowngradeNews CoverageCOCOVita Coco1.5507 of 5 stars$37.02+0.8%$32.14-13.2%+38.6%$2.10B$494.86M37.09294Insider TradeNAPADuckhorn Portfolio1.4066 of 5 stars$11.09+0.1%$10.01-9.7%+18.6%$1.63B$425.91M26.38430Positive NewsWESTWestrock Coffee2.7557 of 5 stars$7.08+1.6%$11.25+58.9%-27.8%$666.85M$836.72M-8.221,399Positive NewsBRCCBRC1.8666 of 5 stars$3.00-1.0%$6.50+116.7%-22.0%$638.22M$395.62M-37.88840Positive NewsCASKHeritage DistillingN/A$2.79-7.0%N/AN/A$14.38M$8.08M0.00N/ANews CoverageIBGInnovation Beverage GroupN/A$1.00+2.1%N/AN/A$8.35M$3.15M0.00N/ANews CoveragePositive NewsGap Up Related Companies and Tools Related Companies DEO Alternatives KDP Alternatives STZ Alternatives BF.B Alternatives COCO Alternatives NAPA Alternatives WEST Alternatives BRCC Alternatives CASK Alternatives IBG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ABEV) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ambev S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ambev With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.